SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-006308
Filing Date
2019-02-11
Accepted
2019-02-11 17:28:24
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tv512982_s3.htm S-3 240216
2 EXHIBIT 5.1 tv512982_ex5-1.htm EX-5.1 18554
3 EXHIBIT 23.1 tv512982_ex23-1.htm EX-23.1 2611
4 EXHIBIT 23.2 tv512982_ex23-2.htm EX-23.2 3713
5 GRAPHIC tv512982_pg02.jpg GRAPHIC 8232
6 GRAPHIC tv512982_pg03.jpg GRAPHIC 7549
7 GRAPHIC tv512982_pg04.jpg GRAPHIC 3710
8 GRAPHIC tv512982_pg01.jpg GRAPHIC 11012
  Complete submission text file 0001144204-19-006308.txt   308729
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229609 | Film No.: 19586657
SIC: 8731 Services-Commercial Physical & Biological Research